Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Perrone

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Cancers|July 30, 2020
<i>TP53</i> Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard ChemotherapyFrancesco Graziano, Nicholas W Fischer, Irene Bagaloni, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining MethodLorenzo Nibid, Erica Iannaccone, Elisabetta Maffei, et al.
Journal of Cellular Physiology|September 22, 2010
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastasesDaniele Santini, Giuseppe Perrone, Ilaria Roato, et al.
Pathologica|July 8, 2025
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUMVincenzo L'Imperio, Giulia Capitoli, Giorgio Cazzaniga, et al.
Cell Death & Disease|November 17, 2017
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cellsFrancesca Zalfa, Vincenzo Panasiti, Simone Carotti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2022
Development and Validation of a Score for Fibrotic Nonalcoholic SteatohepatitisFederica Tavaglione, Oveis Jamialahmadi, Antonio De Vincentis, et al.
International Journal of Cancer|November 11, 2010
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcomeRaffaela Barbano, Massimiliano Copetti, Giuseppe Perrone, et al.
Oncotarget|September 19, 2015
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patientsBruno Vincenzi, Chiara Cremolini, Andrea Sartore-Bianchi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2017
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationaleAndrea Casadei Gardini, Luca Faloppi, Serena De Matteis, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2020
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumabAnnamaria Ruzzo, Francesco Graziano, Irene Bagaloni, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Cancers|July 30, 2020
<i>TP53</i> Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard ChemotherapyFrancesco Graziano, Nicholas W Fischer, Irene Bagaloni, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining MethodLorenzo Nibid, Erica Iannaccone, Elisabetta Maffei, et al.
Journal of Cellular Physiology|September 22, 2010
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastasesDaniele Santini, Giuseppe Perrone, Ilaria Roato, et al.
Pathologica|July 8, 2025
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUMVincenzo L'Imperio, Giulia Capitoli, Giorgio Cazzaniga, et al.
Cell Death & Disease|November 17, 2017
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cellsFrancesca Zalfa, Vincenzo Panasiti, Simone Carotti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2022
Development and Validation of a Score for Fibrotic Nonalcoholic SteatohepatitisFederica Tavaglione, Oveis Jamialahmadi, Antonio De Vincentis, et al.
International Journal of Cancer|November 11, 2010
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcomeRaffaela Barbano, Massimiliano Copetti, Giuseppe Perrone, et al.
Oncotarget|September 19, 2015
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patientsBruno Vincenzi, Chiara Cremolini, Andrea Sartore-Bianchi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2017
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationaleAndrea Casadei Gardini, Luca Faloppi, Serena De Matteis, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2020
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumabAnnamaria Ruzzo, Francesco Graziano, Irene Bagaloni, et al.
Pageof 12